Get the Stockscreener App
1.10
4.76%
0.05
Century Therapeutics Inc Stock (IPSC) Forecast
The Century Therapeutics Inc (IPSC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.7324, representing a +784.76% increase from the current price of $1.10. The highest analyst price target is $9.6233, and the lowest is $9.8415.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IPSC Price Target
Average 9.2686
(+742.60% Upside)
Is Century Therapeutics Inc (IPSC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.74 | Neutral |
| STOCH(9,6) | 8.3885 | Buy |
| STOCHRSI(14) | 17.87 | Buy |
| MACD(12,26) | -0.0839 | Sell |
| ADX(14) | 17.46 | Neutral |
| William %R | -84.21 | Buy |
| CCI(14) | -86.40 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2235
Sell
|
1.1989
Sell
|
| MA20 |
1.3533
Sell
|
1.2797
Sell
|
| MA50 |
1.3777
Sell
|
1.3929
Sell
|
| MA100 |
1.5142
Sell
|
1.6375
Sell
|
| MA200 |
2.376
Sell
|
1.9811
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, IPSC could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IPSC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.74 indicates that IPSC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.3885 indicates that IPSC is oversold. This indicates that IPSC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.87 indicates that IPSC is oversold. This suggests that IPSC price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.46 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -86.4 indicates that IPSC is still oversold but not to an extreme extent.
Long-term IPSC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Century Therapeutics Inc financial reports and earnings history, Century Therapeutics Inc (IPSC) stock could reach $14.43 by 2030, $140.92 by 2040 and $207.16 by 2050. See the projected annual prices until 2050 of the Century Therapeutics Inc stock below:
- Century Therapeutics Inc (IPSC) is expected to reach an average price of $62.32 in 2035, with a high prediction of $63.78 and a low estimate of $62.90. This indicates an $5,565% rise from the last recorded price of $1.10.
- Century Therapeutics Inc (IPSC) stock is projected to chart a bullish course in 2040, with an average price target of $141.41, representing an $12,755% surge from its current level. The forecast ranges from a conservative $11.59 to a sky-high $140.92.
- Our analysts predict Century Therapeutics Inc (IPSC) to jump 8,114% by 2045, soaring from $90.61 to an average price of $90.36, potentially reaching $92.61. While $90.61 is the low estimate, the potential upside is significant.
- Century Therapeutics Inc (IPSC) stock is expected to climb by 2050, reaching an average of $204.83, a $18,521% jump from its current level. However, a wide range of estimates exists, with high and low targets of $207.16 and $205.17, respectively, highlighting the market's uncertainty.
Century Therapeutics Inc Stock (IPSC) Year by Year Forecast
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2025
Century Therapeutics Inc Stock (IPSC) is expected to reach an average price of $9.2686 in 2025, with a high prediction of $12.46 and a low estimate of $6.0784. This indicates an +742.60% rise from the last recorded price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $10.24 | $9.8415 | $9.6233 | +831.21% |
| February, 2025 | $10.41 | $11.03 | $10.74 | +845.98% |
| March, 2025 | $13.05 | $10.43 | $12.36 | +1,086% |
| April, 2025 | $12.19 | $12.84 | $12.46 | +1,008% |
| May, 2025 | $10.70 | $12.02 | $11.34 | +873.07% |
| June, 2025 | $7.7962 | $9.2012 | $9.2743 | +608.74% |
| July, 2025 | $8.2092 | $7.7474 | $8.2086 | +646.30% |
| August, 2025 | $8.1617 | $8.3869 | $7.9011 | +641.97% |
| September, 2025 | $6.6342 | $7.6442 | $7.5223 | +503.10% |
| October, 2025 | $6.0872 | $6.5472 | $6.2804 | +453.38% |
| November, 2025 | $8.6397 | $6.0784 | $6.2747 | +685.42% |
| December, 2025 | $10.57 | $10.34 | $10.22 | +861.16% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2026
The predicted value for Century Therapeutics Inc (IPSC) in 2026 is set at an average of $7.904. Estimates vary from a peak of $10.29 to a trough of $5.5146, indicating an +618.54% surge from the present price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.05 | $10.07 | $10.29 | +813.20% |
| February, 2026 | $9.1976 | $9.5076 | $9.5758 | +736.15% |
| March, 2026 | $9.8001 | $9.9001 | $9.5701 | +790.92% |
| April, 2026 | $9.3732 | $9.4332 | $9.6013 | +752.11% |
| May, 2026 | $8.6556 | $8.9056 | $8.6358 | +686.87% |
| June, 2026 | $7.7981 | $8.0881 | $8.3462 | +608.92% |
| July, 2026 | $7.3911 | $7.4211 | $7.6593 | +571.92% |
| August, 2026 | $7.0636 | $7.1136 | $7.0967 | +542.14% |
| September, 2026 | $6.7167 | $6.7467 | $6.8542 | +510.60% |
| October, 2026 | $6.6941 | $6.6979 | $6.5991 | +508.55% |
| November, 2026 | $5.9316 | $6.2216 | $6.4697 | +439.23% |
| December, 2026 | $5.4746 | $5.5146 | $5.8828 | +397.69% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Century Therapeutics Inc (IPSC) is $17.55, with a high forecast of $35.10 and a low forecast of $0.00627. This indicates an +1,496% increase from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9371 | $3.7671 | $4.3252 | +167.01% |
| February, 2027 | $1.3995 | $1.8195 | $2.3477 | +27.23% |
| March, 2027 | $0.9826 | $0.872 | $1.0101 | -10.67% |
| April, 2027 | $0.815 | $0.155 | $1.205 | -25.91% |
| May, 2027 | $0.3625 | $0.00627 | $1.2133 | -67.05% |
| June, 2027 | $25.85 | $0.05 | $25.36 | +2,250% |
| July, 2027 | $29.34 | $31.53 | $31.43 | +2,568% |
| August, 2027 | $30.14 | $31.36 | $31.06 | +2,640% |
| September, 2027 | $31.20 | $32.89 | $34.29 | +2,736% |
| October, 2027 | $35.16 | $31.90 | $31.78 | +3,096% |
| November, 2027 | $34.46 | $35.54 | $34.43 | +3,032% |
| December, 2027 | $36.29 | $35.76 | $35.10 | +3,199% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2028
In 2028, Century Therapeutics Inc (IPSC) is projected to reach an average price of $29.39, with a high projection of $35.82 and a low estimate of $22.97. This indicates an +2,572% rise from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $36.07 | $36.04 | $35.82 | +3,179% |
| February, 2028 | $33.52 | $34.44 | $34.91 | +2,947% |
| March, 2028 | $33.10 | $33.15 | $32.53 | +2,909% |
| April, 2028 | $32.05 | $32.46 | $33.09 | +2,814% |
| May, 2028 | $33.79 | $34.08 | $34.08 | +2,972% |
| June, 2028 | $32.12 | $32.62 | $33.26 | +2,820% |
| July, 2028 | $29.33 | $31.86 | $31.72 | +2,566% |
| August, 2028 | $26.85 | $26.91 | $28.47 | +2,341% |
| September, 2028 | $25.66 | $26.92 | $27.06 | +2,233% |
| October, 2028 | $26.34 | $26.42 | $26.11 | +2,295% |
| November, 2028 | $23.84 | $24.05 | $25.13 | +2,067% |
| December, 2028 | $22.42 | $22.97 | $22.31 | +1,938% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2029
The 2029 price forecast for Century Therapeutics Inc Stock (IPSC) is $20.30 on average, with a high prediction of $25.70 and a low estimate of $14.89. This represents an +1,745% increase from the previous price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $26.19 | $22.38 | $25.41 | +2,281% |
| February, 2029 | $25.42 | $25.55 | $25.70 | +2,211% |
| March, 2029 | $24.00 | $24.40 | $25.05 | +2,082% |
| April, 2029 | $23.84 | $23.42 | $23.63 | +2,067% |
| May, 2029 | $22.79 | $23.10 | $23.01 | +1,972% |
| June, 2029 | $21.35 | $21.55 | $22.29 | +1,841% |
| July, 2029 | $20.05 | $20.22 | $20.72 | +1,723% |
| August, 2029 | $18.92 | $18.94 | $19.50 | +1,620% |
| September, 2029 | $17.43 | $17.51 | $18.30 | +1,485% |
| October, 2029 | $16.41 | $16.53 | $17.03 | +1,392% |
| November, 2029 | $15.44 | $15.51 | $16.04 | +1,304% |
| December, 2029 | $14.86 | $14.89 | $15.14 | +1,251% |
Century Therapeutics Inc Stock (IPSC) Price Forecast for 2030
Century Therapeutics Inc Stock (IPSC) is expected to reach an average price of $32.15 in 2030, with a high forecast of $61.43 and a low forecast of $2.8599. This signifies an +2,822% surge from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.37 | $13.47 | $14.43 | +1,115% |
| February, 2030 | $11.09 | $12.09 | $12.86 | +908.22% |
| March, 2030 | $9.0054 | $9.0354 | $10.12 | +718.67% |
| April, 2030 | $6.6403 | $6.8903 | $7.7166 | +503.66% |
| May, 2030 | $5.6564 | $5.854 | $5.9215 | +414.22% |
| June, 2030 | $3.6213 | $3.6513 | $5.0076 | +229.21% |
| July, 2030 | $3.5775 | $3.585 | $3.2325 | +225.22% |
| August, 2030 | $59.89 | $2.8599 | $54.25 | +5,345% |
| September, 2030 | $57.30 | $60.15 | $59.85 | +5,109% |
| October, 2030 | $64.09 | $59.29 | $58.83 | +5,726% |
| November, 2030 | $56.53 | $58.56 | $61.43 | +5,039% |
| December, 2030 | $58.95 | $58.73 | $58.95 | +5,259% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):